FBRX insider transactions
Forte Biosciences Inc. (FBRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for FBRX
- SEC Form 4 filed by Director Doberstein Stephen K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kapoor Shivpreet Singh4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Vincent Richard G4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Gryska David W4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Brun Scott C.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kornfeld Steven4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Riley Antony A4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Wagner Paul A.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Officer Wagner Paul A.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 83,178 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A bought $254,833 worth of shares (9,680 units at $26.33), converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 31% to 41,741 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 134 shares and converted options into 375 shares, increasing direct ownership by 0.76% to 31,840 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. covered exercise/tax liability with 98 shares and converted options into 1,250 shares, increasing direct ownership by 1% to 82,092 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 134 shares, increasing direct ownership by 0.77% to 31,599 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 1% to 80,940 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.71% to 31,218 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 18 shares, increasing direct ownership by 2% to 79,788 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Gryska David W4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Vincent Richard G4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kapoor Shivpreet Singh4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Doberstein Stephen K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Brun Scott C.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kornfeld Steven4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Officer Wagner Paul A.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Finck Barbara K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.72% to 30,997 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 78,556 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A bought $124,998 worth of shares (22,514 units at $5.55), increasing direct ownership by 273% to 30,776 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 133 shares and converted options into 375 shares, increasing direct ownership by 3% to 8,262 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 2% to 77,470 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kapoor Shivpreet Singh4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Vincent Richard G4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 3 filed by new insider Kapoor Shivpreet Singh3 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 3 filed by new insider Vincent Richard G3 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Eichenfield Lawrence4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Gryska David W4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Kornfeld Steven4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Doberstein Stephen K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Finck Barbara K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Williams Donald Allen4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Director Brun Scott C.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- CHIEF FINANCIAL OFFICER Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 200,504 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Officer Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,907,971 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 194,474 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,879,174 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Finck Barbara K4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Riley Antony A4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- SEC Form 4 filed by Wagner Paul A.4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Chen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 3,073 shares, increasing direct ownership by 5% to 93,405 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,841 shares, increasing direct ownership by 3% to 188,444 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 4,109 shares, increasing direct ownership by 1% to 1,850,377 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. bought $7,525 worth of shares (10,000 units at $0.75), increasing direct ownership by 0.55% to 1,823,236 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. bought $14,551 worth of shares (20,520 units at $0.71), increasing direct ownership by 1% to 1,813,236 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. bought $19,276 worth of shares (29,776 units at $0.65), increasing direct ownership by 2% to 1,792,716 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. bought $30,468 worth of shares (51,203 units at $0.60), increasing direct ownership by 3% to 1,762,940 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Wagner Paul A. bought $3,220 worth of shares (7,366 units at $0.44), increasing direct ownership by 0.43% to 1,711,737 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Chen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 2,593 shares, increasing direct ownership by 6% to 88,978 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,241 shares, increasing direct ownership by 3% to 182,910 units (SEC Form 4)4 - Forte Biosciences, Inc. (0001419041) (Issuer)